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Abstract
The human small intestine is a key site for interactions between the intestinal
microbiota and the mucosal immune system. Here we investigated the
immunomodulatory properties of representative species of commonly dominant
small-intestinal microbial communities, including six streptococcal strains (four
Streptococcus salivarius, one S. equinus, one S. parasanguinis) one Veillonella
parvula strain, one Enterococcus gallinarum strain, and Lactobacillus plantarum
WCFS1 as a bench mark strain on human monocyte-derived dendritic cells. The
different streptococci induced varying levels of the cytokines IL-8, TNF-a, and IL-
12p70, while the V. parvula strain showed a strong capacity to induce IL-6. E.
gallinarum strain was a potent inducer of cytokines and TLR2/6 signalling. As
Streptococcus and Veillonella can potentially interact metabolically and frequently
co-occur in ecosystems, immunomodulation by pair-wise combinations of strains
were also tested for their combined immunomodulatory properties. Strain
combinations induced cytokine responses in dendritic cells that differed from what
might be expected on the basis of the results obtained with the individual strains. A
combination of (some) streptococci with Veillonella appeared to negate IL-12p70
production, while augmenting IL-8, IL-6, IL-10, and TNF-a responses. This
suggests that immunomodulation data obtained in vitro with individual strains are
unlikely to adequately represent immune responses to mixtures of gut microbiota
communities in vivo. Nevertheless, analysing the immune responses of strains
representing the dominant species in the intestine may help to identify
immunomodulatory mechanisms that influence immune homeostasis.
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Introduction
The human intestine is home to a myriad of different microbial organisms, most
of which are bacteria [1] and collectively known as microbiota. The intestinal
microbiota is of particular interest because it plays an essential role in the
maturation and development of the mucosal immune system in early life [2, 3]
and the preferential tolerance induction to harmless antigens at mucosal sites
[4, 5]. The contribution of individual microbes to the mechanisms that maintain
immune homeostasis are just beginning to be understood [1, 6, 7], but their
importance is highlighted by the disturbances in microbiota composition
associated with several intestinal-related diseases including obesity, multiple
sclerosis, inflammatory bowel diseases, and type 1 diabetes [3, 8, 9, 10, 11, 12, 13].
Research on this topic has been biased towards the analysis of fecal samples that
only provide information about the microbiota at the end of gastrointestinal (GI)
tract [13, 14, 15, 16], meaning that, the immune-influences driven by microbial
communities in the upper intestinal tract have been largely neglected [17]. This is
mainly attributable to the limited accessibility of the small intestine. Nevertheless,
the Peyer’s patches (PP) of the small intestine are major sites for sampling of
luminal antigens, including bacteria, and the induction of adaptive immune
responses. Antigen sampling by the follicle–associated epithelium (FAE) over-
laying the lymphoid follicles of the PP is facilitated by the lack of mucin secreting
goblet cells and the presence of specialized Microfold cells (M cells) [2, 18, 19].
Bacteria sampled by M cells in the FAE are transported intact to the sub-epithelial
dome of PP where dendritic cells (DCs) play a key role in bacterial handling and
the induction of subsequent immune responses (see [20] for a review). Recently,
PP dendritic cells were shown to sample bacteria and antigens through M cell-
specific transcellular pores [21, 22]. Additionally, CX3CR1+ cells in the epithelium
expressing DC or macrophage markers have been shown to sample luminal
bacteria (and other luminal constituents) directly in the lumen by passing
protrusions through the paracellular space of the epithelium without disrupting
epithelial integrity [23, 24, 25].
While both the human small and large intestinal microbiota encompasses
anaerobes belonging to the Clostridium clusters, the marked difference between
these intestinal niches is a microbial composition predominated by facultative
anaerobes, including the streptococci and Veillonella bacteria in the small intestine
[17, 26, 27] (Leimena and Van den Bogert, et al., Unpublished data). The co-
occurrence of these genera may in part depend on their potential for metabolic
interaction as shown in the oral cavity [28] and previously postulated for the small
intestine [17]. Support for this notion comes from the high expression of genes
involved in primary carbohydrate transport systems by the small intestinal
streptococci [17], indicating a role for the Streptococcus populations as primary
fermenters of diet-derived simple sugars in the human small intestine.
Characterization of small-intestinal bacterial streptococci revealed that the small
intestine is inhabited by a variety of Streptococcus lineages that belong to S.
parasanguinis, S. equinus, and S. salivarius species. These lineages displayed
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considerable phenotype variability in terms of carbohydrate utilization capacities
[29, 30], which was in excellent agreement with their capacities predicted on basis
of their genome sequences [30]. With the exception of streptococci, the lactic acid
bacteria are generally present at low abundance in the small intestine microbiota
[26, 30, 31] (Leimena and Van den Bogert, et al., Unpublished data), but
nevertheless display a substantial level of phylogenetic richness in individuals, as
was also concluded for members of the genus Enterococcus [29]. The enterococci
are common colonizers of the GI tract, but have a less attractive reputation
because of the pathogenic potential of specific members of this genus [32].
Considering the prominent role of DCs in modulation of the small-intestinal
immune system the aim of the current study was to investigate the
immunomodulatory properties of different small-intestinal Enterococcus,
Streptococcus, and Veillonella isolates [29], with a special focus on the latter two
genera because of their predominance in the small-intestinal ecosystem.
Materials and Methods
Bacterial strains
Six Streptococcus strains (with known genome sequences; [29, 30]), an Enterococcus
gallinarum HSIEG1 strain [33], and a Veillonella parvula HSIVP1 strain [29, 34],
as well as the reference strain Lactobacillus plantarum WCFS1 [35] were used in
the immunoassays (Table 1). The streptococcal strains were representative isolates
of 6 distinct phylogenetic lineages, as determined by DNA fingerprinting,
belonging to: S. parasanguinis (1 strain; HSISM1), S. equinus (1 strain; HSISB1),
and S. salivarius (4 strains; HSISS1-4; Table 1) [29, 30]. The streptococcal and
Enterococcus strains were grown in Mitis-Salivarius (MS) medium [29], while
Veillonella was grown in medium described in the DSMZ catalogue (Medium 136)
under anoxic N2 atmosphere. Lactobacillus plantarum WCFS1 was grown in
Mann-Rogosa Sharpe (MRS) medium (Becton Dickinson, Breda, The
Netherlands). Fresh culture media did not induce any cytokine responses (data
not shown). All strains were twice subcultured overnight successively, after
which the streptococci and the Enterococcus strains had an average OD600 of
1.3 (¡ standard deviation of 0.2), while the V. parvula strain and WCFS1 had
OD600 of approximately 0.5 and 2.5, respectively. The bacteria suspsensions were
diluted in PBS (GIBCO) to a final OD600 of 1.
Differentiation and maturation of dendritic cells
The study was approved by the Wageningen University Ethical Committee and
was performed according to the principles of the Declaration of Helsinki. Buffy
coats were obtained from the Sanquin Blood bank Nijmegen, the Netherlands. A
written informed consent was obtained before sample collection. Human
monocytes were isolated from blood using a combination of Ficoll density
centrifugation and cell separation using CD14-specific antibody coated magnetic
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microbeads (Miltenyi Biotec, Leiden, the Netherlands). The purity of isolated
CD14+ cell fraction was greater than 90% and cell-viability was above 95% in all
experiments. To generate immature DC (iDCs), the purified CD14+ cells were
cultured for 6 days in RPMI 1640 medium (Invitrogen, Breda, the Netherlands),
supplemented with 100 units/ml penicillin G (Invitrogen), 100 mg/ml strepto-
mycin (Invitrogen), 50 ng/ml IL-4 (R&D systems, Abingdon, United Kingdom)
and 50 ng/ml granulocyte-macrophage colony-stimulating-factor (GM-CSF)
(R&D systems). GM-CSF and IL-4 were added to differentiate the monocytes into
myeloid DCs. On day 6 approximately 16106 iDCs were stimulated with LPS
(1 mg/ml) or the different bacteria at a cell to bacteria ratio of approximately 1:1
and 1:10 for 24 hours. As anticipated and as a consequence of the
supplementation of the cell-media with antibiotics, no bacterial growth was
observed during this period. Non-stimulated iDCs were used as a negative
control.
Analyses of cell surface markers and measurement of cell death
by flow cytometry
On days 3, 6, and 8 the percentage of viable cells was measured by flow cytometry
(FACSCanto II, BD, San Diego, USA). Live, apoptotic and necrotic cells were
discriminated by staining with Annexin V and propidium iodide (PI) according to
the manufacturer’s protocol. The cells were analysed using flow cytometry
(FACSCanto II, BD, San Diego, USA) and the BD FACSDiva software. Cells that
are negative for both Annexin V and PI are not apoptotic or necrotic as
translocation of the membrane phospholipid phosphatidylserine has not occurred
and the plasma membrane is still intact. Therefore, Annexin V and PI double
negative cells were considered as viable cells, whereas both single and double
positive cells were regarded as non-viable [36]. On days 3 to 8 the viability of the
cells was between 60 and 95%. There were no significant differences in cell death
Table 1. Strains used in this study.
Species Strain identifier
Streptococcus parasanguinis HSISM1*
Streptococcus equinus HSISB1*
Streptococcus salivarius HSISS1*
Streptococcus salivarius HSISS2*
Streptococcus salivarius HSISS3*
Streptococcus salivarius HSISS4*
Veillonella parvula HSIVP1*
Enterococcus gallinarum HSIEG1*
Lactobacillus plantarum WCFS1**
*: Strain was cultivated from ileostoma effluent [29, 30].
**: Strain was cultivated from human saliva [35].
doi:10.1371/journal.pone.0114277.t001
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between the bacteria-stimulated cells and the non-stimulated (negative control) or
LPS-stimulated (positive control) cells.
On day 8, cells were also stained with fluorescence-conjugated monoclonal
antibodies specific for CD83, CD86 or their isotype-matched controls (BD
biosciences, San Diego, USA) and analysed by flow cytometry (FACSCanto II, BD,
San Diego, USA) to check the maturation and activation status of the cells. CD83
and CD86 are highly expressed on DCs after stimulation with known maturation
factors (e.g. LPS) compared to non-stimulated immature dendritic cells. The
expression of CD83 and CD86 from different human donors can vary
considerably after stimulation with different stimuli so for comparison the data
was normalized to the values (100%) obtained using a standard amount of LPS
added to cells from each donor.
Cytokine assays
Supernatants from the DC stimulation assays were collected after stimulation for
24 hours, and analysed for the presence of cytokines (IL-1b, IL-6, IL-8, IL-10, IL-
12p70 and TNF-a) using a cytometric bead-based BD Human inflammation kit
that enables multiplex measurements of soluble cytokines in the same sample
[37], according to the manufacturer’s protocol (BD biosciences, Breda, the
Netherlands). The sensitivity-limits of detection were as follows: IL-1b 7.2 pg/ml,
IL-6 2.5 pg/ml, IL-8 3.6 pg/ml, IL-10 3.3 pg/ml, IL-12p70 1.9 pg/ml and TNF-a
0.7 pg/ml. The flow cytometry data were analysed using the BD FCAP software
(Figure S1). Unless stated otherwise, cytokine secretion in the remainder of the
paper are based on stimulation of iDCs with a DC to bacteria ratio of
approximately 1:10.
Disruption of bacterial cells and spent medium collection
To determine whether the S. equinus strain might possess an immunomodulatory
component, which suppresses cytokine secretion, the S. equinus as well as S.
salivarius strain 4 were disrupted using a cell disruptor (LaBiosystems, Constant
systems, Waalwijk, The Netherlands). The latter strain was chosen as a control
strain because of its capacity to induce considerable cytokine production levels in
dendritic cells. In addition spent medium was collected, by centrifugation of an
overnight culture of S. equinus or S. salivarius strain 4.
TLR2/6 assay
TLR2/6 signalling capacities of the bacterial strains were determined using a
reporter assay with Human Embryonic Kidney (HEK) 293 (Invivogen, Toulouse,
France) cells expressing human TLR2 and TLR6 heterodimers that recognize
lipoteichoic acid (LTA) and lipoprotein lipid anchors of Gram-positive bacteria
[38]. The TLR2/6 signalling assay was performed essentially as previously
described [39]. Briefly, HEK293 cells were transformed with human TLR2/6 and
pNIFTY, a NF-kB luciferase reporter construct (Invivogen, Toulouse, France).
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HEK293 cells transformed with only the pNIFTY did not respond to Pam2CSK
(20 ng/ml) (synthetic agonist of TLR2/6) demonstrating the dependency of NF-
kB activation on co-expression of hTLR2/6 receptor [39]. The cells were plated at
a concentration of 66104 cells per well in DMEM medium (Invitrogen). Cells
were then stimulated with the different bacterial strains, or Pam2CSK (20 ng/ml)
as a positive control or with medium alone (negative control) followed by
incubation at 37 C˚ for 6 hours under a 5% CO2 atmosphere. Thereafter, the
medium was replaced with Bright glow (Promega, Leiden, the Netherlands), and
the plates shaken for 5 minutes before measuring the luminescence in a
Spectramax M5 (Molecular Devices, Sunnyvale, United States). HEK293 cells not
expressing TLR receptors that harbour pNIFTY were used as the negative control
in the NF-kB assays.
Statistical analysis
Mixed general linear model using restricted maximum likelihood (REML) was
used to determine the statistical differences within donors between cytokine
produced by DCs stimulated with the different bacterial strains. A two-sided p-
value of 0.05 or lower was considered to be significant. The statistical analysis for
the cytokine secretion by dendritic cells after mono-stimulation with bacterial
strains, disrupted strains, and spent medium a One-Way ANOVA test was used to
compare the cytokine secretion between bacteria stimulated cells, as the group size
(n52) was not sufficient using REML. The statistical analysis (REML) was
performed by using SAS software (version 9.1, SAS Institute Inc., Cary, NC, USA)
and the One-Way ANOVA test Graphpad Prism5.
Results
Small-intestinal bacteria differentially affect DC maturation and
activation
S. parasanguinis HSISM1, S. equinus HSISB1, 4 different S. salivarius strains
(HSISS1-4), E. gallinarum HSIEG1, and V. parvula HSIVP1 strains obtained from
the human small intestine were investigated for their capacity to induce
maturation and activation of immature monocyte-derived DCs from donors. The
DCs were stimulated for 24 hours with different strains at DC to bacteria ratios of
1 and 10. The expression of the surface marker CD83 (maturation marker) and
CD86 (maturation marker and co-stimulatory molecule) were measured to
determine maturation and activation status of the DCs. The mean fluorescence
intensity (MFI) of dendritic cells was normalized to LPS stimulation (Figure 1).
Stimulation of the DCs by all strains with the high dose (1 to 10) resulted in
higher maturation and activation marker expression compared to the medium
control, except for CD83 induced by S. equinus (Table S1). Furthermore,
significant differences (p,0.05) were observed between the different ratios for S.
parasanguinis, and S. salivarius 1, 2, and 4. The induction of the expression of the
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surface markers CD83 differed markedly among the different species used as DC
stimulants. S. salivarius strain 1, 3, and 4 and E. gallinarum induced highest
expression (Figure 1). Moreover, while V. parvula induced moderate levels of
CD83 expression, whereas it was one of the strongest inducers CD86 expression
among the tested strains.
DC cytokine responses to bacterial isolates from the small
intestine
The small-intestinal Streptococcus, Veillonella and Enterococcus strains were further
investigated for their capacity to induce cytokine secretion by monocyte-derived
iDCs. In addition, L. plantarum WCFS1 was employed as a benchmark strain that
was analysed several times before [40, 41, 42, 43]. The IL-10 and TNF-a levels
induced by L. plantarum WCFS1 were comparable to a previous study [41].
Noteworthy, L. plantarum WCFS1 induced considerably higher amounts of IL-8,
IL-6, and IL-10, higher than the streptococci, albeit that this was based on DCs
derived from 2 donors (Table S2).
Although cytokine responses upon stimulation with the different bacterial
strains varied between the different donors, the induced immune profiles were
consistent (Figure 2). The V. parvula strain elicited a moderate induction of the
production of the cytokines IL-8, IL-1b, IL-10, and TNF-a. In contrast to the
Streptococcus strains, V. parvula stimulated hardly any IL-12p70 secretion in DCs,
whereas its capacity to induce IL-6 was substantially higher, albeit that this was
not significant (Figure 2; Table S2, S3, S4, and S5).
Figure 1. MFI of stained cell surface markers CD83 (A) and CD86 (B) by monocyte derived dendritic cells. Immature DCs were used as the negative
control and LPS as the positive control. Dendritic cells were derived from monocytes of 5 different human donors.
doi:10.1371/journal.pone.0114277.g001
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Although, the cytokine response between donors for the E. gallinarum strain
varied, the averaged induced cytokine amounts by E. gallinarum strain
consistently were the highest among the tested strains (Figure 2; Table S2),
indicating that the immune system response is more pronounced if triggered with
this strain compared to the streptococci.
Although the IL-1b (16–41 pg/ml) and IL-10 (7–78 pg/ml) levels induced by
the streptococci varied (Table S2), the levels were relatively low. In agreement with
what has previously been described for members of the S. bovis species group [44],
the S. equinus strain tested here consistently induced low levels of cytokines
(Figure 2). This was especially clear for the significantly lower IL-8, IL-6, IL-10,
Figure 2. Cytokine secretion by dendritic cells after stimulation with bacterial strains. Dendritic cells
were derived from monocytes of 5 human different donors. Cytokine levels are expressed as relative values of
the highest inducing strain (100% cytokine levels (pg/ml): IL-8: 17598; IL-1b: 41; IL-6: 4775; IL-10: 206; TNF-
a: 5151; IL-12p70: 2397; Table S2). Lines represents the average secreted cytokine amounts and faded
colours represent the interval between the upper and the lower SEM. SEM values higher than 100% are not
visualized. *: Cytokine responses determined using DCs derived from 2 different human donors (Figure 5,
Table S2).
doi:10.1371/journal.pone.0114277.g002
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and TNF-a levels induced by S. equinus compared to those by the S. salivarius
strains (p,0.05; Table S2, S3, S4, and S5).
The Streptococcus strains showed substantial differences in their ability to
induce the production of the chemokine IL-8 (5231–17147 pg/ml) and the pro-
inflammatory cytokines IL-6 (161–2221 pg/ml), TNF-a (86–4933 pg/ml), and IL-
12p70 (81–1416 pg/ml; Figure 2; Table S2, S3, S4, and S5). This illustrates that
the strains tested here elicited distinct cytokine profiles, which is in agreement
with earlier observations that revealed distinct DC responses to closely related
species and strains [43, 45]. The immune response profiles elicited by the S.
salivarius strains 1 and 4 were not significantly different (Table S3, S4, and S5),
except for IL-1b that was induced at a low (but significantly different) level by
both strains (see also above). This corroborates earlier observations on the close
relatedness of these two S. salivarius strains that were based on genetic
fingerprinting and physiological evaluations [29, 30].
S. equinus is not immunosuppressive
As the S. equinus strain elicited a low immune response compared to the other
strains tested (Figure 2), we hypothesized that this strain might possess an
immunomodulatory component that suppresses cytokine secretion. Therefore, we
co-stimulated DCs with LPS (10 ng/ml) and S. equinus or S. salivarius strain 4. A
lower LPS dose was used (10 ng/mL) compared to the previous immune assay
(mono-stimulations) to be able to modulate the cytokines response. S. salivarius
strain 4 was chosen as a control strain because it induced considerable cytokine
production in dendritic cells. Moreover, the genomic lineage that this strain
belongs to was highly predominant in ileostoma effluent and appears to be among
the genomic lineage that is ubiquitously found in the human small intestine,
supporting the relevance of selecting this strain for comparative reasons [29, 30].
The S. equinus strain did not significantly modulate the cytokine levels induced by
LPS stimulation. Nevertheless, the amount of IL-6 produced by DCs stimulated
with S. equinus and LPS together, was higher than the sum of the levels induced by
the two separate stimuli, suggesting that these stimuli may synergistically induce
the secretion of this cytokine by DCs rather than the hypothesized immunosup-
pressive effect of S. equinus. A qualitatively similar and quantitatively significant
synergistic effect on IL-6 production was also observed when DCs were co-
stimulated with S. salivarius and LPS (Figure 3). Co-stimulation of DCs with LPS
and spent culture supernatant from either of the two bacterial strains also
consistently elevated production of most cytokines (except for TNF-a) as
compared to LPS alone (Figure 3), although this effect was not significant and
appeared to be smaller as compared to the co-stimulation by the bacterial cells.
Taken together these results establish that S. equinus displays no detectable
immunosuppressive effect on dendritic cell cytokine production levels, but
appears to be able to moderately enhance cytokine production in response to LPS.
Immunomodulation by Small-Intestinal Strains
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Involvement of TLR2 and TLR6 in innate immune signalling by
small-intestinal Streptococcus and Veillonella strains
TLR2/6- mediated activation of NF-kB is potentially one of the major pathways
for DC activation via LTA or lipoproteins derived from the cell envelope of
bacteria. Therefore, we tested the TLR2/6 signalling capacities of the Streptococcus
and Veillonella strains in a reporter assay using HEK293 cells expressing human
TLR2 and TLR6 heterodimers that recognize lipoteichoic acid (LTA) and
lipoprotein lipid anchors of Gram-positive bacteria [38]. The results demon-
strated that most strains are capable of triggering NF-kB activation via TLR2/6
dependent signalling. A notable exception is the S. equinus strain that did not
significantly induce TLR2/6 signalling in this reporter assay (Figure 4), which is
analogous to its failure to induce high levels of cytokine production in DCs (see
above). Similarly, the strong DC-response elicited by E. gallinarum stimulation
was reflected in its TLR2/6 signalling capacity, where this strain classified as one of
the strongest TLR2/6 stimulators among the strains tested. These results suggest a
certain degree of congruency between the capacity of individual strains to elicit
TLR2/6 signalling in HEK293 NF-kB reporter cells, and their capacity to stimulate
high levels of cytokine production in iDCs.
Co-stimulation of dendritic cells with streptococci and Veillonella
Based on the frequent co-occurrence of the Streptococcus and Veillonella spp. in
various habitats associated with the human body [17, 28], we evaluated the
cytokine responses that were elicited in iDCs that were co-stimulated with one of
the small intestinal Streptococcus strains in combination with the V. parvula strain.
Though cytokine production levels differed for DCs derived from different
donors, the overall response profiles induced by a combination of the two species
differed from the levels anticipated on basis of mono-stimulation with the
individual strains (Figure 5).
As an example of the specific co-stimulatory effects, the amounts of TNF-a
secreted upon co-stimulation of iDCs with V. parvula and the S. parasanguinis, S.
equinus, and S. salivarius strain 2 were considerably increased in comparison to
those observed with mono-stimulations with either one of the streptococci or the
V. parvula strain alone. Notably, this effect was not observed for co-stimulation of
V. parvula together with S. salivarius strain 1, which actually led to decreased
TNF-a production as compared to the cognate mono-stimulations. The DC
response to co-stimulation with V. parvula and S. salivarius strain 3 and 4,
appeared to vary between multiple donors. Finally, while mono-stimulation with
the Streptococcus strains induced variable amounts of IL-8 and generally low
amounts of IL-6 and IL-10 production in DCs, co-stimulation of DCs commonly
led to higher amounts of secreted IL-8, IL-10, and IL-6 (Figure 5; Table S6). The
Figure 3. Cytokine secretion by dendritic cells after mono-stimulation with bacterial strains, disrupted strains, and spent medium. Dendritic cells
were derived from monocytes from 2 human donors. Spent medium was tested with or without LPS.
doi:10.1371/journal.pone.0114277.g003
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latter observation was especially obvious for co-stimulation with V. parvula and
the S. equinus or S. salivarius strains 1, 3, and 4, which by themselves induced
among the lowest amounts of IL-8 and IL-6 of all tested bacteria (Table S6), but in
combination with V. parvula induced high amounts of these cytokines in iDCs
(Figure 5; Table S6).
Interestingly, the postulated synergy between V. parvula and the streptococci
with respect to stimulation of production of IL-8, IL-6, IL-10, and TNF-a might
be relatively specific for these combinations of bacteria, as co-stimulation of iDCs
with V. parvula and L. plantarum WCFS1 suppressed production of these
cytokines, leading to the lowest IL-8, IL-6, IL-10, and TNF-a amounts observed in
these co-stimulation analyses (Figure 5; Table S6). These observations suggest that
immune cell stimulation with combinations of some streptococci and V. parvula
may elicit responses that are specific for the combined bacterial stimuli, leading to
immune-synergistic effects that could not be predicted from respective mono-
stimulations with either of the bacteria.
Extrapolation of these in vitro immune (co-)stimulation profiles to the in vivo
situation that encompasses the exposure of the immune system to bacterial
communities rather than single strains is far from trivial. Nonetheless, certain
trends could be seen in our in vitro results of streptococcal and V. parvula co-
stimulation, suggesting at least a partial consistency in the co-stimulatory
capacities of two species. This notion is further illustrated by the high similarity of
the immune profiles elicited by co-stimulation with V. parvula and S. salivarius
strain 1 or 4 (Figure 5), which is in good agreement with the close relatedness of
these streptococcal strains ([29, 30]; see also above).
Figure 4. TLR2/6 signalling capacities of bacterial strains. HEK293 cells were incubated with the small-
intestinal strains at a cell to bacteria ratio of 1:10, PAM2CSK as a positive control and medium as a negative
control (n53). This figure is representative out of two hTLR2/6 assays.
doi:10.1371/journal.pone.0114277.g004
Immunomodulation by Small-Intestinal Strains
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Discussion
Individual GI commensals (e.g. Faecalibacterium prauznitsii [46] and Bacteroides
fragilis [47, 48]) affect the host immune system in specific ways (see [49] for a
recent review). Given that the human small intestine is an important region to
study host-microbe interactions, we evaluated the immunomodulatory properties
of Streptococcus, Veillonella, and Enterococcus strains isolated from the small
intestine. The strains used (especially valid for the streptococci [29]) can be
regarded as representatives of distinct phylogenetic lineages that were identified
among a large panel of isolates obtained from the human small intestine
ecosystem. The Streptococcus strains tested here, have previously been subjected to
in depth analysis, including physiological studies focussing on their carbohydrate
utilizing capacities [29] and the determination of their complete genome
sequences [30]. The current study revealed that these Streptococcus strains differ
significantly in their ability to elicit cytokine production responses in iDCs as well
as their capacity to activate NF-kB responses via TLR2/6. These findings are in
agreement with previous reports that conclude that significantly different
Figure 5. Cytokine secretion by dendritic cells after mono-stimulation with tested strains and co-stimulation with V. parvula. Dendritic cells were
derived from 2 human donors. Mono-stimulations (Mono)_ and co-stimulations (Co) were both performed at a cell to bacteria, or a cell to a combination of
two strains, ratio of approximately 1:10. See table S6 for cytokine values.
doi:10.1371/journal.pone.0114277.g005
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immunomodulatory properties can be observed in the comparison of closely
related species [45] and strains [43]. However, stimulation of iDCs with S.
salivarius strain 1 and 4 induced similar amounts of different cytokines, which is
in agreement with their highly conserved genetic content and physiological
characteristics [29, 30]. Among the strains tested, S. salivarius strain 2 was the least
effective in activating and maturating responses in iDCs, but at the same time was
identified as one of the strongest inducers of TLR2/6 signalling, which is likely due
to the difference in phagocytosis capacity between dendritic cells and HEK293
cells or that bacterial components are shielding certain microbe-associated
molecular patterns (MAMPs) The cytokine responses of the small intestinal
streptococci were quite similar to other Streptococcus strains, including pathogenic
S. suis strains although these elicited higher IL-12 (up to 6948 pg/ml) in DCs [50].
However, the small intestinal Streptococcus strains tested here are not known to be
virulent, although remnants of streptococcal virulence genes were identified in
their genomes [30]. Similarly, remnants of virulence related genes were also
encountered in the genomes of strains of the yoghurt-associated species S.
thermophilus [51], suggesting that benign streptococci may share functions with
related pathogens.
Compared to the streptococci, the small intestinal E. gallinarum strain appeared
to be consistently more potent in inducing cytokine production in iDC and was
one of the strongest inducers of TLR2/6 signalling, which is in agreement with
earlier studies that report on the highly immune-stimulating capacities of
enterococci [52, 53].
In contrast to the other streptococci tested in this study, DCs were relatively
unresponsive to the S. equinus strain, which also induced negligible TLR2/6-
mediated signalling. Interestingly, the amounts of cytokines produced by DCs co-
stimulated with S. equinus and LPS were higher compared to stimulation with LPS
alone, indicating a synergistic immunostimulatory effect. The low immune
response to S. equinus may therefore be due to the modification of conserved
MAMPs reducing their capacity to signal through TLRs and NLRs or shielding
effects (e.g. due to capsule polysaccharide). Close relatives of the S. equinus strain
(e.g. S. gallolyticus subsp gallolyticus UCN34 [54]) have a less attractive reputation
and are known to evade the host immune system and have been associated with
GI tract malignancies [44]. Notably, genome mining of the S. equinus strain [30]
revealed gene repertoires similar to the capsular operon encoded by S. gallolyticus
subsp gallolyticus UCN34 [54] (data not shown), which was postulated to shield
the bacterial cell from the host immune system [44]. Further comparative analyses
could elucidate the genetic relatedness (e.g. coding capacities for virulence factors)
between the S. equinus strain tested here and potentially pathogenic close relatives.
As Streptococcus and Veillonella spp. have been found to co-occur in various
microbial ecosystems associated with humans and are proposed to have metabolic
interactions [17, 28], the small-intestinal isolates from both genera were tested in
co-stimulation experiments. Although the numbers of donors is relatively low in
these experiments, the results suggested that combinations of streptococcal and
Veillonella strains elicited an immune response profile that was distinct from the
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profile that was predicted on basis of the corresponding mono-stimulations. Some
streptococci when combined with Veillonella substantially augmented IL-8, IL-6,
IL-10, and TNF-a responses. Determining the exact mechanism underlying these
co-stimulation effects is not trivial.
Our results imply that integrated responses to multiple bacteria or bacterial
fragments could result in cytokine responses that are distinct from those
anticipated on basis of the sum of single strain immune stimulation profiles.
These observations may be particularly relevant for the mucosal-associated
lymphoid tissue (e.g., Peyer’s Patches’ isolated lymphoid follicles), where multiple
bacteria could be sampled by M-cells and transported to underlying dendritic
cells. Cytokines induced by these DCs are predicted to influence activation of
antigen-specific T cell responses after migration to the T cell areas of the PP or
lymph nodes. Additionally, interaction bacteria or fragments of bacteria with
CXCR1+ cells in the epithelium may influence local cytokine production and
immunity. Our current knowledge and understanding of these interactions within
the microbiota community as well as their interaction with the host (immune)
system is an area of intense investigation but further mechanistic studies are
needed to decipher the contribution of different bacteria and complex
communities of bacteria to immunity and homeostasis. Immunomodulation
analyses with a variety of well characterized bacterial isolates from the microbiota,
would be a good starting point to identify potential immunomodulatory effects
(including immunosuppression) for members of the microbiota. Deciphering of
the underlying molecular mechanisms and identification of the bacterial effector
molecules is a necessary subsequent step to unravel the molecular basis for
individual bacteria-immune interactions. Insights in these individual molecular
mechanisms of interaction for various bacterial species and strains could
accelerate the deciphering of the complex and multifactorial interplay between the
microbiota and the host immune system in vivo. In addition, high resolution in
vivo measurements of the molecular responses to specific microbes can
complement mechanistic in vitro studies by providing the necessary in vivo
support for the molecular mechanisms unravelled with the help of in vitro
systems. Mono-association (or simplified community colonization) studies in
gnotobiotic animal models could provide an attractive reductionist model to
extrapolate in vitro findings to an in vivo situation [55, 56, 57, 58, 59, 60].
Subsequent mono-association studies with derivatives of the same bacterial
species or strains that lack one or more of their (immune) effector molecules
could enable the in vivo establishment of the molecular interaction mechanisms
proposed on basis of in vitro observations. As an example, approaches like this
have elucidated how B. fragilis and its zwitterionic polysaccharide PSA are able to
shape the host immune system (see [47, 48] for recent reviews). These reductionist
in vivo and in vitro models offer a unique set-up to take the essential initial steps
towards understanding the complexity of the interplay between the microbiota
and the host in the intestine and its possible consequences for the overall
physiology of the host organism, including its immune system status.
Alternatively, the molecular responses elicited in the human intestine mucosa by
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specific bacteria can in some cases directly be determined in vivo, which is
exemplified by the in depth analysis of transcriptional responses in the duodenal
mucosa of healthy human volunteers upon the consumption of dietary lactobacilli
[40, 45]. Such measurements may serve to guide in vitro studies that aim to
decipher the underlying molecular mechanisms. The latter approach has the
considerable advantage that the starting point for the in vitro mechanistic work is
based on relevant in vivo observations in humans, and may therefore suffer less
from the risk that responses in animal models cannot be translated to humans. In
this context, it would be of interest to determine the in vivo (or ex vivo) small
intestine mucosal responses to the typical small intestinal microbiota represen-
tatives that were studied here [17, 26], to generate reference datasets to guide in
vitro mechanistic studies aimed to unravel the immunomodulatory capacities of
these microbes.
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